Experts Provide a New Framework for Systemic Sclerosis Treatment
A multidisciplinary team of scleroderma specialists developed a framework for a comprehensive and sustainable approach to treating scleroderma.
A multidisciplinary team of scleroderma specialists developed a framework for a comprehensive and sustainable approach to treating scleroderma.
Researchers investigated whether 8% silver-fiber gloves reduced the burden of Raynaud phenomenon in patients with scleroderma.
Researchers evaluated the correlation of nail videocapillaroscopy patterns and digital thermal monitoring variables in systemic sclerosis.
In this perspective, Tracy M. Frech, MD, MS, discusses the diagnosis and management of systemic sclerosis.
A panel of experts in the field of capillaroscopy and microcirculation published a consensus view on standardizing capillaroscopic image acquisition and analysis.
A thorough work-up can differentiate between primary and secondary forms, mitigating progression of a more severe underlying disease.
As part of Scleroderma Awareness Month, physicians specializing in the management of scleroderma discuss mitigating effects of scleroderma-related pain and improving quality of life for their patients.
Treatment with the endothelin-1 blocker macitentan did not reduce the incidence of new digital ulcers over 16 weeks.
If conservative treatment with medications such as dihydropyridine, calcium channel blockers, alpha-adrenergic blockers, and phosphodiesterase-5 inhibitors is unsuccessful, clinicians can consider chemical sympathectomy, botulinum neurotoxin injection, and fat pad grafting.